Stock futures were little changed Tuesday evening at the start of the overnight session, taking a pause after the S&P 500 closed out at its highest level since March 5....
How do we protect those at the frontline facing COVID-19 head on? Sorrento Therapeutics (SRNE) is on it.Looking at billions of antibodies, the company identified a small group that demonstrated the ability to block the S1 protein's interaction with human angiotensin-converting enzyme 2 (ACE2), the receptor used for viral entrance into human cells. Based on this, SRNE wants to develop an antibody cocktail against SARS-CoV-2, the virus that causes COVID-19, that is still effective even if mutations occur.Weighing in for Dawson James, analyst Jason Kolbert tells clients that SRNE’s antibody, STI-1499, has already exhibited a strong performance in an early clinical setting. Expounding on this, he stated, “What was also equally impressive was the low dose, which suggests the antibody ‘fits’ its target extraordinarily well and, as such, can work at a very low dose. This could translate into the ability to scale up rapidly to millions of treatments at a...
Jesse Edgerton, J.P. Morgan Senior Economist, joins The Final Round to discuss predictions for what the U.S. GDP will look like in the coming quarters and his forecast for unemployment numbers amid COVID-19....
On Tuesday, stocks finished higher, though they pared gains after Bloomberg report late in the session that the U.S. was considering sanctioning Chinese officials and firms over new national security efforts imposed on Hong Kong....
By some estimates, nearly one in four Americans is out of work. A steady stream of bankruptcies has begun, both out loud and quietly, and many businesses have shuttered for good. The full extent of the damage wrought by the … Continue reading ->The post Why Is the Stock Market Up? appeared first on SmartAsset Blog....
On Tuesday, Novavax announced that it was moving forward with its clinical trials for its coronavirus vaccine. This comes as a Merck announced it would begin to develop its own vaccine with IAVI and that the company would purchase Austrian vaccine maker Themis Bioscience. Yahoo Finance’s Anjalee Khemlani joins The Final Round to break down the latest news about the coronavirus....
* Optimism about economic recoveries overshadowed US-China tensions. * U.S. President's advisor Kudlow said the trade deal with China is intact, for now. * EUR/USD is bullish in the short-term, but speculative interest hesitating ahead of 1.1000.The EUR/USD pair flirted with the 1.1000 level this Tuesday, as risk-appetite took over the financial world. News that a U.S. biotech firm is starting human tests of a new COVID-19 vaccine coupled with economic reopenings boosted hopes of economic recoveries. After a long weekend, stocks returned with a vengeance posting substantial gains throughout the different sessions. Mounting optimism also lifted U.S. Treasury yields, with the yield on the benchmark 10-year Treasury note reaching an intraday high of 0.71%.Tensions between the U.S. and China persist but were temporarily set aside. Trump's advisor Kudlow said that the President is not concerned about the trade deal that's intact for the moment. He added that Trump's main concerns...